Hemogenyx Pharmaceuticals buy melinda
Start price
06.06.21
/
50%
€0.017
Target price
06.06.22
€0.050
Performance (%)
-35.29%
End price
07.06.22
€0.011
Summary
This prediction ended on 07.06.22 with a price of €0.011. The BUY prediction by melinda for Hemogenyx Pharmaceuticals performed very badly with a performance of -35.29%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Hemogenyx Pharmaceuticals | - | - | - | - |
iShares Core DAX® | -1.114% | 5.062% | 24.922% | 25.215% |
iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% | 44.324% |
iShares Nikkei 225® | 2.113% | 8.218% | 22.231% | 12.395% |
iShares S&P 500 | 2.038% | 7.448% | 30.358% | 43.899% |
According to melinda what are the pros and cons of Hemogenyx Pharmaceuticals for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Hemogenyx Pharmaceuticals diskutieren
Buy mit Kursziel 0,05
In the thread Trading Hemogenyx Pharmaceuticals
Die von melinda gewählte maximale Laufzeit wurde überschritten